Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse D Bloom

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
Elife|October 17, 2014
Improving pandemic influenza risk assessmentColin A Russell, Peter M Kasson, Ruben O Donis, et al.
Science Immunology|October 10, 2025
Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunizationSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoproteinSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Nature|December 23, 2021
Broadly neutralizing antibodies target a haemagglutinin anchor epitopeJenna J Guthmiller, Julianna Han, Henry A Utset, et al.
Nature Communications|October 8, 2025
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Nature Microbiology|October 14, 2025
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza virusesAlexandra A Abu-Shmais, Gray Freeman, Adrian Creanga, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Molecular Biology and Evolution|March 24, 2022
Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike FunctionDarren P Martin, Spyros Lytras, Alexander G Lucaci, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
Elife|October 17, 2014
Improving pandemic influenza risk assessmentColin A Russell, Peter M Kasson, Ruben O Donis, et al.
Science Immunology|October 10, 2025
Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunizationSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Biorxiv : the Preprint Server for Biology|December 23, 2024
Defining a highly conserved B cell epitope in the receptor binding motif of SARS-CoV-2 spike glycoproteinSameer Kumar Malladi, Deepika Jaiswal, Baoling Ying, et al.
Nature Microbiology|September 22, 2021
Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktailJinhui Dong, Seth J Zost, Allison J Greaney, et al.
Nature|December 23, 2021
Broadly neutralizing antibodies target a haemagglutinin anchor epitopeJenna J Guthmiller, Julianna Han, Henry A Utset, et al.
Nature Communications|October 8, 2025
Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.
Nature Microbiology|October 14, 2025
Cross-neutralizing and potent human monoclonal antibodies against historical and emerging H5Nx influenza virusesAlexandra A Abu-Shmais, Gray Freeman, Adrian Creanga, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Identification of a broad and potent V3 glycan site bNAb targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Molecular Biology and Evolution|March 24, 2022
Selection Analysis Identifies Clusters of Unusual Mutational Changes in Omicron Lineage BA.1 That Likely Impact Spike FunctionDarren P Martin, Spyros Lytras, Alexander G Lucaci, et al.
Pageof 26